Hyundai Rotem's credit rating upgraded to A- Company's financial profitability improves thanks to self-rescue efforts
Translated by Kim So-in 공개 2022-05-24 08:05:25
이 기사는 2022년 05월 24일 08:01 thebell 에 표출된 기사입니다.
South Korean credit rating agencies upgraded their credit ratings on Hyundai Rotem on improved financial structure.Korea Ratings and NICE Investors Service upgraded their ratings on Hyundai Rotem from BBB+ with a positive outlook to A- with a stable outlook. Korea Investors Service revised up a short-term credit rating on the company from A3+ to A2-.
The company’s credit rating was downgraded to BBB+ three years ago due to weak profitability. The domestic agencies retained their ratings at A+ until the end of 2015, but downgraded them to A- in 2019 and to BBB+ in 2020.
In the first half of 2021, they revised up Hyundai Rotem’s outlook from a stable to a positive. This was attributable to the company’s efforts to focus more on the profitmaking defense unit and reduce reliance on the plant business.
Market insiders expect the company’s revenue to continue growing in the longer term thanks to large order backlog and new orders. Hyundai Rotem’s order backlog amounted to some 10 trillion won ($7.9 billion) as of the end of March, winning new orders worth 3 trillion won per year.
The railroad business also got back on track. Hyundai Rotem recorded revenue of 2.87 trillion won in 2021 on a consolidated basis, up 3.1% from a year ago. Its revenue increased by 3.7% year-over-year to 677.4 billion won in the first quarter of this year.
Hyundai Rotem has carried out its self-rescue measures since 2020. It sold some of its land in Uiwang, Gyeonggi Province, to Hyundai Mobis for 87.8 billion won and secured 81.2 billion won by selling its entire stake in its subsidiary Green Air to Hyundai Steel. It also increased its capital by 235.4 billion won through a conversion of convertible bonds.
With the latest credit rating upgrade, the company is expected save borrowing costs when raising funds in the future. It issued commercial paper worth 30 billion won on May 12 and 5 billion won on May 16 based on its new credit rating to repay debts. (Reporting by Ji-won Kim)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
관련기사
best clicks
최신뉴스 in 전체기사
-
- [제약바이오 R&D 인사이더스]'라면의 원조' 삼양식품의 바이오 도전 시작은 '대체육'
- 뷰노, '비파괴검사' 강자 이번엔 '안저분석' 혁신기기로
- [thebell note]기획바이오는 '사기'다?
- [바이오텍 상장 재도전기]허리띠 졸라맨 벤처 10년, 건강한 비만약 실마리 찾다
- 명문제약, 영업이익 감소에도 개량신약 드라이브
- '조직재생' 티앤알바이오팹, 첫 베팅 '메디컬코스메틱'
- [K-바이오텍 열전]'생태계 조력자' 바이오리서치AI, 설립 2년차에 '매출'
- [thebell interview]KT의 엔젠바이오, 클리아랩 인수로 기술에 '실적까지'
- 한독, 70주년 기념 전 임직원에 '스톡옵션' 100주 쐈다
- '큐리진' 물질 산 종근당, CGT 투자서 자체개발로 확장